Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Central Mechanisms and Treatment Response of Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor

NCT07041203 is registered in ClinicalTrials.gov with Kristina Simonyan as lead sponsor.

NCT NCT07041203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07041203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Central Mechanisms and Treatment Response of Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
Lead sponsor
Kristina Simonyan
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laryngeal dystonia, spasmodic dysphonia, voice tremor